Patient Information: Summary of Product Characteristics
Vinpocetina Covex 10 mg tablets
vinpocetina
Read the entire summary of product characteristics carefully before starting to take this medication, as it contains important information for you.
Contents of the Summary of Product Characteristics
Vinpocetina Covex is indicated for the treatment of cognitive impairment symptoms related to cerebral vascular pathology. Before starting treatment, non-vascular degenerative disease (Alzheimer's disease) should be ruled out.
Do not take Vinpocetina Covex
Warnings and precautions
Consult your doctor or pharmacist before starting to take Vinpocetina Covex:
Children and adolescents
The use of Vinpocetina Covex is not recommended in children and adolescents under 18 years of age.
Other medications and Vinpocetina Covex
Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.
In particular, inform your doctor if you are taking any of the following medications:
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Vinpocetina Covex should not be administered to pregnant or breastfeeding women (see section 2 - "Do not take Vinpocetina Covex").
Driving and using machines
This medication may affect your reaction ability, which can impair your ability to drive and use machinery, especially when taken with alcohol.
Vinpocetina Covex contains lactose
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Follow your doctor's instructions for taking this medication exactly. If you are unsure, consult your doctor or pharmacist again.
The recommended dose is half or one tablet (5 or 10 mg) of vinpocetina three times a day orally. It is recommended to take the tablets during meals, without chewing them.
If you take more Vinpocetina Covex than you should
There are no known cases of intoxication due to overdose with Vinpocetina Covex.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Vinpocetina Covex
Do not take a double dose to make up for forgotten doses. If you forget a dose, wait for the next scheduled dose.
If you stop taking Vinpocetina Covex
Do not stop treatment unless your doctor tells you to. Consult your doctor or pharmacist before stopping treatment with Vinpocetina Covex.
If you have any other questions about using this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone will experience them.
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
Very rare(may affect up to 1 in 10,000 people):
Reporting side effects:
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this summary of product characteristics.
You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaram.es
By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Do not use this medication after the expiration date stated on the packaging after CAD. The expiration date is the last day of the month indicated.
This medication does not require any special storage temperature.
Store in the original packaging to protect it from light.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and unused medications at the SIGRE collection point in your pharmacy. If you have any questions, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition of Vinpocetina Covex
Appearance and packaging of the product
White, round tablets with the Covex logo on one side and a score line on the other. The tablet can be divided into equal doses.
Packaging: The tablets are packaged in PVC/aluminum blisters of 15 tablets and presented in boxes of 45 or 90 tablets.
Marketing authorization holder and manufacturer
Marketing authorization holder:
COVEX, S.A.
C/ Acero nº 25, Pol. Ind. Sur, 28770
Colmenar Viejo (Madrid) - Spain
Tel: 91 845 02 00
e-mail: info@covex.com
Manufacturer:
COVEX, S.A.
C/ Acero nº 25, Pol. Ind. Sur, 28770
Colmenar Viejo (Madrid) - Spain
Date of the last revision of this summary of product characteristics: September 2020.
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS)
http://www.aemps.gob.es/.